Silo Pharma, Inc. - 8-K Filing

Silo Pharma will implement a 1-for-15 reverse stock split effective June 2, 2026. The number of issued and outstanding shares will decrease from approximately 16.267 million to about 1.084 million, with the common stock trading under the same symbol 'SILO' on Nasdaq starting June 3, 2026. (Items: 8.01 Other Events)

SEC EDGAR ·

Tickers: $SILO

Read the full article at SEC EDGAR

More Regulatory news